Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation
Grace Christou(University of Ottawa), David Allan(University of Ottawa), Christopher Bredeson, Melanie Tokessy(Ottawa Hospital), Antonio Giulivi(Health Canada), Natasha Kekre(Ottawa Hospital), Isabelle Bence‐Bruckler(University of Ottawa), Harold Atkins(University of Ottawa), Doris Neurath(Ottawa Hospital), Jason Tay(University of Ottawa), Sheryl McDiarmid(Ottawa Hospital), Mitchell Sabloff(University of Ottawa), Lothar Huebsch(University of Ottawa), Alan Tinmouth(Center for Biologics Evaluation and Research), Elianna Saidenberg(Ottawa Hospital), Dawn Sheppard(University of Ottawa), William Petrcich(Ottawa Hospital)
Cited by 19
Related Papers
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
|Annals of Internal Medicine|2012|1.1k
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|598
Age of Transfused Blood in Critically Ill Adults
|New England Journal of Medicine|2015|559